Investors weighing exposure to U.S. managed care often compare CI (The Cigna Group) and UNH (UnitedHealth Group), two of the largest players in health insurance and health services. Cigna operates through its Cigna Healthcare and Evernorth Health Services segments, with significant scale in pharmacy benefits, while UnitedHealth combines its UnitedHealthcare insurance arm with the fast-growing Optum health services platform. This stock comparison matters for both long-term investors assessing sector positioning and active traders tracking relative performance. Although the two companies share exposure to similar medical-cost and regulatory pressures, their business models, valuation profiles, and recent momentum diverge in ways that can shape portfolio decisions.
CI has traded in the upper portion of its 52-week range in recent weeks, supported by steady earnings growth and a value-oriented valuation. The company's core segments span employer and government health coverage through Cigna Healthcare and a diversified pharmacy, care, and benefits platform through Evernorth, which includes its Express Scripts PBM operations.
Sentiment has been shaped by Cigna's 2026 Investor Day, where management introduced a "Lead to One" strategy centered on complex care, personalization, and AI, alongside a roughly $3 billion multi-year modernization and productivity initiative. The company also reaffirmed its near-term guidance and outlined a long-term target for double-digit adjusted earnings growth. At the same time, the stock carries a relatively low P/E ratio and a dividend yield above 2%, a profile that has drawn value-focused commentary. Regulatory pressure on the PBM industry, including rebate and transparency debates, remains a key watch item for the name.
UNH has been among the more closely followed managed-care recovery stories over recent months. Following a difficult prior-year stretch marked by elevated medical costs and federal scrutiny, the company has worked to rebuild investor confidence through pricing discipline, benefit redesign, and a renewed focus on its integrated Optum platform, which spans care delivery, pharmacy, and health analytics.
Recent market activity has reflected improving fundamentals. In its latest quarterly report, UnitedHealth posted an adjusted earnings beat and raised its full-year outlook, aided by a lower medical care ratio (a measure of premiums spent on medical claims) and stronger performance in its Optum Health unit. Analysts have largely maintained constructive ratings, citing margin recovery and visibility into 2027 and 2028. Offsetting these positives are ongoing risks, including Medicare Advantage membership shifts, Department of Justice investigations into billing practices, and the reputational and financial effects of the Change Healthcare data breach, which regulators have said affected roughly 100 million individuals.
Tickeron operates a large library of AI-driven trading bots spanning thousands of individual tickers, but only a select group is highlighted in the Trending AI Robots section. These bots differ meaningfully in trading style, strategy, timeframe, performance statistics, and the sets of tickers they trade, ranging from short-horizon momentum models to longer-term trend-following systems. By curating the strongest and most suitable performers for current market conditions, the section helps traders filter a broad universe of automated strategies down to those showing the most relevant recent results. Whether you are comparing names like CI and UNH or scanning the broader market, exploring these automated tools can add a data-driven layer to your research process.
The two companies differ most clearly in business mix and valuation. Cigna generates a substantial share of earnings from pharmacy and care services, giving it a diversified, asset-light model that currently trades at a notable discount, with a forward P/E near 9 versus a mid-20s multiple for UnitedHealth. UnitedHealth, by contrast, offers deeper integration between its insurance book and Optum's care and data services, a structure that historically supported premium growth but that has also concentrated regulatory attention.
On momentum, UnitedHealth has led in recent weeks, driven by a guidance raise, a declining medical care ratio, and broad analyst support, while Cigna's shares have consolidated near recent highs ahead of its next earnings release. Risk profiles also differ: Cigna's exposure centers on PBM reform and rebate transparency, whereas UnitedHealth faces billing investigations, Medicare Advantage attrition, and cybersecurity fallout. For value-oriented investors, Cigna's discount and yield are the draw; for those prioritizing demonstrated earnings momentum and recovery catalysts, UnitedHealth has offered a steadier near-term trend.
Weighing trend consistency, stability, and visible catalysts, Tickeron's AI currently leans toward UNH over CI. The signal reflects UnitedHealth's improving medical-cost trajectory, its raised earnings outlook, and a more persistent upward trend in relative performance, even as Cigna presents a more attractive valuation. This is a probabilistic assessment based on observable technical and fundamental factors rather than a definitive forecast, and the balance between the two names could shift as new earnings data and policy developments emerge.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 50-day moving average for CI moved above the 200-day moving average on October 16, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 31 of 51 cases where CI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 61%.
The Momentum Indicator moved above the 0 level on November 10, 2026. You may want to consider a long position or call options on CI as a result. In 64 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 68%.
CI moved above its 50-day moving average on October 07, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CI crossed bullishly above the 50-day moving average on October 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 62%.
Following a +3.25% 3-day Advance, the price is estimated to grow further. Considering data from situations where CI advanced for three days, in 224 of 355 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
The Aroon Indicator entered an Uptrend today. In 169 of 276 cases where CI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 61%.
The 10-day RSI Indicator for CI moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In 21 of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at 58%.
The Moving Average Convergence Divergence Histogram (MACD) for CI turned negative on October 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 30 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 59%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.
CI broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 33 (best 1 - 100 worst), indicating outstanding price growth. CI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 37 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 43 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock slightly better than average.
The Tickeron Valuation Rating of 52 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.820) is normal, around the industry mean (3.520). P/E Ratio (12.077) is within average values for comparable stocks, (126.353). Projected Growth (PEG Ratio) (0.739) is also within normal values, averaging (0.786). CI has a moderately high Dividend Yield (0.021) as compared to the industry average of (0.009). P/S Ratio (0.264) is also within normal values, averaging (0.569).
The Tickeron SMR rating for this company is 55 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
UNH moved above its 50-day moving average on October 14, 2026 date and that indicates a change from a downward trend to an upward trend. In 28 of 42 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 67%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 31 of 48 cases where UNH's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 65%.
The 10-day moving average for UNH crossed bullishly above the 50-day moving average on October 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 44%.
Following a +2.78% 3-day Advance, the price is estimated to grow further. Considering data from situations where UNH advanced for three days, in 186 of 330 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.
The Aroon Indicator entered an Uptrend today. In 106 of 245 cases where UNH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 43%.
The 10-day RSI Indicator for UNH moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 35 similar instances where the indicator moved out of overbought territory. In 18 of the 35 cases, the stock moved lower in the following days. This puts the odds of a move lower at 51%.
The Momentum Indicator moved below the 0 level on November 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on UNH as a result. In 57 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 69%.
The Moving Average Convergence Divergence Histogram (MACD) for UNH turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 25 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 53%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UNH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 52%.
UNH broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating fairly steady price growth. UNH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 58 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.594) is normal, around the industry mean (3.520). P/E Ratio (25.266) is within average values for comparable stocks, (126.353). Projected Growth (PEG Ratio) (1.025) is also within normal values, averaging (0.786). UNH has a moderately high Dividend Yield (0.024) as compared to the industry average of (0.009). P/S Ratio (0.757) is also within normal values, averaging (0.569).
The Tickeron Profit vs. Risk Rating rating for this company is 96 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UNH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
CI | UNH | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 68 | 15 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 52 Fair valued | 63 Fair valued | |
PROFIT vs RISK RATING 1..100 | 43 | 96 | |
SMR RATING 1..100 | 55 | 58 | |
PRICE GROWTH RATING 1..100 | 33 | 35 | |
P/E GROWTH RATING 1..100 | 37 | 9 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CI's Valuation (52) in the Managed Health Care industry is in the same range as UNH (63). This means that CI’s stock grew similarly to UNH’s over the last 12 months.
CI's Profit vs Risk Rating (43) in the Managed Health Care industry is somewhat better than the same rating for UNH (96). This means that CI’s stock grew somewhat faster than UNH’s over the last 12 months.
CI's SMR Rating (55) in the Managed Health Care industry is in the same range as UNH (58). This means that CI’s stock grew similarly to UNH’s over the last 12 months.
CI's Price Growth Rating (33) in the Managed Health Care industry is in the same range as UNH (35). This means that CI’s stock grew similarly to UNH’s over the last 12 months.
UNH's P/E Growth Rating (9) in the Managed Health Care industry is in the same range as CI (37). This means that UNH’s stock grew similarly to CI’s over the last 12 months.
| CI | UNH | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 58% | 2 days ago 51% |
| Stochastic ODDS (%) | 2 days ago 61% | 2 days ago 65% |
| Momentum ODDS (%) | 2 days ago 68% | 2 days ago 69% |
| MACD ODDS (%) | 2 days ago 59% | 2 days ago 53% |
| TrendWeek ODDS (%) | 2 days ago 51% | 2 days ago 59% |
| TrendMonth ODDS (%) | 2 days ago 62% | 2 days ago 54% |
| Advances ODDS (%) | 3 days ago 63% | 3 days ago 56% |
| Declines ODDS (%) | 7 days ago 56% | 7 days ago 52% |
| BollingerBands ODDS (%) | 2 days ago 51% | 2 days ago 67% |
| Aroon ODDS (%) | 2 days ago 61% | 2 days ago 43% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CI’s FA Score shows that 1 FA rating(s) are green while UNH’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CI’s TA Score shows that 7 TA indicator(s) are bullish while UNH’s TA Score has 5 bullish TA indicator(s).
CI (@Managed Health Care) experienced а -1.30% price change this week, while UNH (@Managed Health Care) price change was -1.57% for the same time period.
The average weekly price growth across all stocks in the @Managed Health Care industry was +1.93%. For the same industry, the average monthly price growth was +4.07%, and the average quarterly price growth was +16.14%.
CI is expected to report earnings on Feb 04, 2027.
UNH is expected to report earnings on Jan 20, 2027.
Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.
A.I.dvisor indicates that over the last year, CI has been loosely correlated with ELV. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if CI jumps, then ELV could also see price increases.
A.I.dvisor indicates that over the last year, UNH has been closely correlated with ELV. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if UNH jumps, then ELV could also see price increases.